In the journal "Healthcare of Kyrgyzstan," a work by physician N. Monolov was published, which conducted a comparative analysis of various surgical treatment methods for prostate adenoma.
Monolov noted that although monopolar transurethral resection of the prostate has long been considered the "gold standard" of therapy, it does not always allow for the complete removal of hyperplastic tissue. This, in turn, increases the likelihood of disease recurrence and may negatively affect the recovery of urinary function.
As part of a retrospective study, specialists examined the surgical outcomes of 320 patients who underwent various types of surgical interventions: monopolar TURP, bipolar plasmakinetic enucleation, and holmium laser enucleation of the prostate. They studied operation-related indicators, the frequency of complications, and the dynamics of clinical symptoms over the year following the intervention.
The study results showed that enucleation techniques are more radical and effective compared to traditional resection. The best results were recorded with holmium laser enucleation, which provided the maximum improvement in functional indicators: the maximum urine flow increased by 3.1 times, and the complication rate was minimal.
Additionally, laser enucleation significantly reduced the length of hospital stay—on average to 2.3 days.
As a result of the conducted research, the specialist concluded that holmium laser enucleation is the safest, most radical, and effective method of surgical treatment for benign prostatic hyperplasia, especially in patients with an enlarged prostate. The expert recommends considering this method as a new priority "gold standard" in the therapy of this condition.
